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Abstract Six mutants (Y26A, C27S, Y29F, Y29P, C30S and
Y26W/Y29P) have been engineered in order to explore the active
site of poplar glutaredoxin (Grx) (Y26CPYC30). The cysteinic
mutants indicate that Cys 27 is the primary nucleophile. Phe is a
good substitute for Tyr 29, but the Y29P mutant was inactive.
The Y26A mutation caused a moderate loss of activity. The
YCPPC and WCPPC mutations did not improve the reactivity of
Grx with the chloroplastic NADP-malate dehydrogenase, a well
known target of thioredoxins (Trxs). The results are discussed in
relation with the known biochemical properties of Grx and
Trx. ß 2002 Federation of European Biochemical Societies.
Published by Elsevier Science B.V. All rights reserved.
Key words: Glutaredoxin; Thioredoxin; Redox regulation;
Dithiol/disul¢de exchange
1. Introduction
Thioredoxin (Trx) and glutaredoxin (Grx) are structurally
related proteins, the major function of which is to reduce
disul¢de bridges on other proteins. Both proteins di¡er by
their mode of reduction and their active site sequence
(YCP[Y/F]C for Grx and WC[G/P]PC for Trx) [1].
Trxs are fairly well characterized in plants, and it has been
shown that there are multiple nuclear genes (close to 20 in the
simple model Arabidopsis thaliana that encode cytosolic, mi-
tochondrial and chloroplastic isoforms) [2]. In the cytosol and
probably mitochondria, Trxs are reduced via NADPH and a
£avoprotein, NADPH Trx reductase. Chloroplastic Trxs are
reduced in the light by a cascade that involves the photosys-
tem I, [2Fe2S] stromal ferredoxin and an iron^sulfur enzyme,
ferredoxin^Trx reductase [3]. The targets of chloroplastic Trxs
are well characterized, notably the redox-regulated fructose-
1,6-bisphosphatase and NADP-malate dehydrogenase (MDH)
[4,5]. Besides the two catalytic cysteines, the active site of Trx
involves the conserved tryptophan residue adjacent to the
most N-terminal cysteine and a buried aspartate residue that
is conserved in all Trx sequences from bacteria to mammalian
systems [6^8]. The redox potentials of Trxs are close to 3300
mV, a value that makes them very e⁄cient reductants of di-
sul¢de bridges [9]. The three-dimensional structure of Trxs is
also very well described, all isoforms have a similar fold with
a central pleated L sheet surrounded by K helices. The attack-
ing cysteine as well as the active site tryptophan are surface-
exposed while the other cysteine is more buried [10].
Grxs are rather well known in bacteria (such as Escherichia
coli), yeast and mammalian systems. In E. coli there are three
Grx genes, at least ¢ve in yeast and apparently only two in
human [11^14]. In all known organisms, Grxs are reduced via
a cascade that involves NADPH, glutathione reductase (GR)
and the tripeptide glutathione [1]. The redox potential of Grx
is estimated to be around 3230 mV [15]. Although the targets
of Grx are not as well characterized as those of Trx, it is quite
clear that Grx is the preferred donor to ribonucleotide reduc-
tase and as e⁄cient as Trx with PAPS reductase [16,17]. On
the other hand, the information about plant Grxs is more
scarce. The questioning of GenBank indicates that there are
also multiple genes in plants with rather large variations at the
active site (from the canonic YCPYC to the less frequent
YCPFC, but also to more exotic forms as GCCMS where
the active site sequence is hardly recognizable). Plant Grxs
have been puri¢ed from several sources (rice and spinach
mostly) [18,19]. The protein was found to possess activity in
the 2-hydroxyethyl disul¢de (HED) reduction assay and also
in the more physiological dehydroascorbate (DHA) reduction
[18]. Quite recently, Grx has been cloned and overproduced
from poplar [20]. It has been shown to be very e¡ective in the
DHA reduction, but also to be a good electron donor to a
new cytosolic peroxiredoxin (Prx) [21]. Quite interestingly,
Trx, Grx and Prx have been found in sieve tubes and the
phloem sap, sometimes in very large amounts, a property
that suggests a role in the long distance transmission of the
redox signal in plants [21^23]. One interesting feature of the
poplar Grx is that it is elongated both on the N- and
C-termini compared to the mammalian or bacterial Grxs
characterized so far. It is thus of interest to investigate the
biochemical reactivity of this type of protein in order to com-
pare those data with the ones obtained with shorter versions
of this protein in distant organisms. We describe in this paper
a series of mutations that help understand the importance of
the amino acids of the active site.
2. Materials and methods
2.1. Materials
Puri¢ed oligonucleotides, restriction enzymes, DNA polymerase
and ligase were either from Eurogentec or from Invitrogen. IPTG,
0014-5793 / 02 / $22.00 ß 2002 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
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NADPH, HED, DHA, reduced glutathione (GSH) and GR were
from Eurogentec, Boehringer, and Sigma. Chromatographic matrices
were from Pharmacia. Kinetic measurements were followed using a
Cary 50 spectrophotometer.
2.2. Plasmids and strains
The plasmid used for cloning and expression was pET-3d which
carries the resistance for ampicillin. When needed, an additional plas-
mid (pSBET, carrying a kanamycin resistance) [24] was used to co-
transform the expression strain E. coli BL21(DE3). The cloning strain
was E. coli DH5K.
2.3. Mutagenesis
Mutagenesis of the cloned cDNAs was e¡ected by PCR. A strategy
similar to the one in [25] was employed, generating two overlapping
mutated fragments and in a second PCR reaction the full length
mutated sequence. The two ‘cloning’ oligonucleotides had the follow-
ing sequences (NcoI and BamHI restriction sites underlined): forward
5P-GGGCCATGGCTGGCAGCCCTGAAGCT-3P ; reverse 5P-GGG-
GGGATCCTCATTCTAGTTTAAAGTCATC-3P.
The mutagenic oligonucleotides had the following sequences (muta-
genic bases in bold): Y26A FOR 5P-ATCTTCTCCAAGTCTGCT-
TGCCCGTATTGT-3P ; Y26A REV 5P-ACAATACGGGCAAGCA-
GACTTGGAGAAGAT-3P ; Y26W^Y29P FOR 5P-TCCAAGTCT-
TGGTGCCCGCCTTGT-3P ; Y26W^Y29P REV 5P-ACAAGGCGGG-
CACCAAGACTTGGA-3P ; C27S FOR 5P-TTCTCCAAGTCTTA-
TAGCCCGTATTGTAAGAAG-3P ; C27S REV 5P-CTTCTTACAA-
TACGGGCTATAAGACTTGGAGAA-3P ; Y29P FOR 5P-TCTTA-
TTGCCCGCCTTGTAAGAAGGCT-3P ; Y29P REV 5P-AGCCTTC-
TTACAAGGCGGGCAATAAGA-3P ; Y29F FOR 5P-TATTGCC-
CGTTTTGTAAGAGG-3P ; Y29F REV 5P-CCTCTTACAAAACG-
GGCAATA-3P ; C30S FOR 5P-TATTGCCCGTATTCTAAGAAGG-
CTAAA-3P ; C30S REV 5P-TTTAGCCTTCTTAGAATACGGGCAA-
TA-3P.
The template used was the construction pET-Grx3 [20]. After di-
gestion with NcoI and BamHI, the full length mutated fragments were
cloned into pET-3d. The mutations were veri¢ed by DNA sequencing
and the recombinant plasmids were used to transform the expression
strain and then ampicillin and kanamycin resistant clones selected.
2.4. Expression and puri¢cation of the recombinant proteins
The transformed E. coli cells were successively multiplied to a ¢nal
volume of ca. 5 l at 37‡C. 100 WM IPTG was added in the exponential
phase and the bacteria harvested by centrifugation for 15 min at
5000Ug. The cells were resuspended in a TE bu¡er (Tris^HCl 30
mM, pH 8.0, EDTA 1 mM) which also contained 14 mM L-mercap-
toethanol for the cysteinic mutants. All subsequent chromatographic
steps were e¡ected in the same bu¡er. The recombinant proteins were
puri¢ed by ammonium sulfate fractionation (50^90%), Sephadex G50
gel ¢ltration and DEAE Sephacel chromatography. The samples were
then concentrated and dialyzed by ultra¢ltration in an Amicon cell
(Millipore) equipped with a YM 10 membrane under nitrogen pres-
sure. The proteins were stored by aliquots, frozen at 320‡C at con-
centrations of ca. 4 mg/ml. The yield was around 10 mg homogeneous
protein per liter culture.
2.5. Biochemical assays
The assays describing the reductions of HED and DHA were per-
formed as described in [20]. The Prx and NADP-MDH assays were as
in [21,26]. The preparations of recombinant Grx, Prx and NADP-
MDH have been described in [20,21,26].
The Prx reaction was e¡ected in 500 Wl cuvettes in the presence of
50 mM K-phosphate bu¡er, 150 WM NADPH, 1 mM GSH, 0.5 U
GR, and 2.5 WM poplar Prx and Grx. The reaction was started by
adding 100 WM H2O2 after 1 min of incubation at 30‡C to permit the
reduction of the system. Activity was measured by following the ox-
idation of NADPH at 340 nm.
The activation medium for NADP-MDH (30 Wl) had the following
composition: 50 mM Tris^HCl pH 8.0, 5 mM dithiothreitol (DTT),
0.8 WM recombinant sorghum NADP-MDH and 20 WM Grx or Trx
as indicated. After 20 min incubation at 20‡C, an aliquot of 20 Wl was
used to determine the activity at 30‡C as described in [5].
The purity of the protein preparations was estimated by SDS^
PAGE as described by Laemmli [27].
3. Results
3.1. E⁄ciency of the mutated Grxs in the ‘classical’ HED and
DHA reduction tests
Fig. 1 shows the reactivity of the various mutants in the
reduction of the non-physiological substrate, HED. Replacing
Tyr 29 by a Phe residue had little e¡ect on the activity, the
protein behaving essentially as the wild-type (WT) enzyme.
On the other hand, introducing a non-aromatic amino acid
instead of either of the Tyr of the active site depressed the Grx
activity (Y26A had a catalytic e⁄ciency half the WT and the
replacement of Tyr 29 by Pro resulted in an inactive protein).
The C30S mutant retained 30% of the activity, but the C27S
protein was inactive.
Essentially similar results were obtained in the DHA reduc-
tion (Fig. 2). When Tyr 29 was replaced by Pro, the protein
was inactive and the replacement of Cys 27 by a serine like-
wise produced an inactive catalyst. Replacing Tyr 26 by an
Ala decreased the catalytic e⁄ciency (ca. 20%). On the other
hand, the Y29F and C30S mutations produced better cata-
lysts. It is especially remarkable that the monocysteinic mu-
tant C30S which contains only Cys 27 is more e⁄cient than
the WT protein (the activity is nearly doubled at every con-
centration tested).
Fig. 1. Reduction of HED by WT and mutated poplar Grxs. All ac-
tivities were measured at 30‡C. After 1 min incubation of the sys-
tem, the reaction was initiated by addition of Grx.
Fig. 2. Reduction of DHA by WT and mutated poplar Grxs. All
activities were measured at 30‡C. After 1 min incubation of the sys-
tem, the reaction was initiated by addition of Grx.
FEBS 25683 21-1-02
N. Rouhier et al./FEBS Letters 511 (2002) 145^149146
3.2. Grx e⁄ciency vs plant type C Prx
It has been demonstrated recently that type C Prx of plants
uses both Trx and Grx as proton donors [21]. It was thus of
interest to determine if the various mutants generated here are
able to sustain the catalytic activity of Prx in this newly de-
scribed reaction. Fig. 3 shows the results of those experiments.
The WT and Y29F mutant show similar activity. On the other
hand, replacing the two Tyr residues by non-aromatic side
chains decreased the catalytic e⁄ciency. Finally, the C30S
mutant retains most of its catalytic e⁄ciency and the C27S
protein is inactive.
3.3. Activation of NADP-MDH by mutated Grxs
Two of the mutations that we have engineered in this work
transform the Grx active site into a Trx-like active site
(YCPPC and WCPPC). It was expected that these mutations
should increase the reactivity of Grx vs the NADP-MDH, a
well characterized target enzyme of Trx. Fig. 4 shows the
reactivity of the various mutants with NADP-MDH. It is
interesting that the WT Grx is able to activate the enzyme
in the presence of DTT with reasonably good e⁄ciency
(nearly half the capacity of the non-physiological Trx h at
the same concentration of 20 WM). All mutants tested showed
catalytic activity, but all mutations decreased the e⁄ciency
except for Y26A. The two mutations that were intended to
mimic the Trx active site (Y29P and Y26W/Y29P) did not
improve the reactivity at all. Interestingly, both the C27S
and C30S mutants retained the capacity to activate the
NADP-MDH but their e⁄ciencies were strongly reduced (to
ca. 25% of the WT).
4. Discussion
4.1. Mutations of the active site cysteines
In the Grx dependent reactions (HED and DHA reduction
and Prx activation), the mutation of Cys 27 leads to a virtu-
ally inactive enzyme. On the other hand, the mutation of Cys
30 into Ser had either a strongly negative e¡ect (HED), a
mildly negative e¡ect (Prx) or a positive e¡ect (DHA). All
these data strongly suggest that Cys 27 is the primary nucle-
ophile of the reaction and that Cys 30 is the backup cysteine.
Similar results have been obtained with the E. coli and human
Grx or all Trxs where the catalytic cysteine is always located
on the N-terminus side [28^30]. It seems thus that the N- and
C-termini extensions of plant Grx do not alter that property.
Additionally, these site-directed mutagenesis experiments in-
dicate that Grx can be quite e⁄cient as a single cysteine cata-
lyst, con¢rming that it can act in the so-called monothiol
pathway [31]. Moreover, these experiments suggest that the
numerous natural monocysteinic versions of Grx that exist
in the databanks are almost certainly functional catalysts.
4.2. Importance of the aromatic residues of the active site
The replacement of the Tyr residue present between the two
catalytic cysteines by a proline leads to a drastic decline in
reactivity. It is clearly essential to keep an aromatic residue in
this position as the Y29F mutant is a very good catalyst in all
Grx dependent reactions tested. This Tyr residue has been
implicated as one of the ligands necessary for the ¢xation of
glutathione to E. coli Grx3 or T4 Grx [11,32]. On the other
hand, it is not necessary to have an aromatic residue in posi-
tion 26 (N-terminus to the catalytic cysteine) as the Y26A
mutant kept at least half of the reactivity of the WT protein.
This is very much in contrast with the case of Trx where the
removal of the Trp adjacent to the catalytic cysteine has a
very strong negative e¡ect [6,33].
4.3. The NADP-MDH is activated by plant Grx and its
mutants
The NADP-MDH has been recognized as a target of Trxs
since a long time. The chloroplastic Trx f is the most e⁄cient,
followed by chloroplastic Trx m, and the cytosolic Trx h [34].
Mammalian Trxs are very poor reductants/activators of this
enzyme [35]. All Trxs which have been demonstrated as capa-
ble of activating this enzyme have either a WCGPC or a
WCPPC active site. By making the Y29P and Y26W/Y29P
mutations, we have engineered proteins with active sites that
have been transformed into YCPPC and WCPPC. It was thus
expected that these mutations could result in Grxs with better
reactivity vs the NADP-MDH. The results in Fig. 4 indicate
clearly that this is not the case as only the Y26A mutant has
an activity comparable to the WT protein and all other mu-
tations decrease the reactivity. It is surprising to observe that
WT Grx is able to induce the activation of the enzyme in the
presence of DTT (see Fig. 4). This activation is dependent on
the concentration of added Grx and on DTT (data not
shown). The WT poplar Grx is not as e⁄cient as the cytosolic
Trx h but more e⁄cient than the human Trx or the Trxs of
Dictyostelium discoideum [35,36]. We have checked that this
reactivity is not due to contaminating E. coli Trx in the re-
combinant Grx preparations. We have indeed quantitated the
Fig. 3. Activity of Prx with WT and mutated Grxs. The activity is
expressed in % of the WT protein. 100% activity is 0.55 vOD/min.
Details of the reaction are given in Section 2.
Fig. 4. Activity of NADP-MDH with WT and mutated Grxs. Activ-
ities are expressed in % of the WT Grx. 100% activity is 0.4vOD/
min. Experimental details are given in Section 2.
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contamination of those preparations by the NTR/DTNB sys-
tem and found that it could not exceed 0.3%. At a Grx con-
centration of 20 WM in Fig. 4, the E. coli Trx concentration is
thus lower than 60 nM, a value at which no detectable
NADP-MDH activation occurs [37]. This activation of
NADP-MDH by Grx is likely to be non-physiological since
GSH could not replace DTT, even in the presence of NADPH
and GR (data not shown). Three additional observations sup-
port the proposal that Grx is indeed not a physiological acti-
vator of NADP-MDH. First, it seems that there are no
chloroplastic sequences for Grx in protein databases. Second,
the redox potential of Grx (normally around 3230 mV) is not
adequate with respect to the ones of the NADP-MDH disul-
¢de bridges (3280 and 3300 mV) for an e⁄cient reaction to
take place [38]. Third, the fact that the C30S mutant keeps a
level of activity similar to the C27S mutant suggests that the
role of Grx in this reaction is non-catalytic. We propose thus
that Grx acts here in a non-catalytic way to modify the acces-
sibility of the active site to DTT which has the right redox
potential. Such a structural role has already been observed in
the case of the interaction between the T7 DNA polymerase
and the E. coli Trx [39]. The results obtained with the C27S
mutant seem to support such a hypothesis since Cys 30 is
widely recognized as the non-catalytic one, a property also
veri¢ed in the other reactions described here.
4.4. Concluding remarks
Mutations similar to those described here have already been
performed either on E. coli Trx to transform it into a Grx or a
DsbA protein [40,41], or on DsbA to transform it into a Grx
or a Trx [42]. In most of these mutants, essentially physico-
chemical characteristics as pKa values and redox potentials
have been determined but few kinetic experiments have been
performed except in [40] where the creation of a CGHC site
has been shown to be accompanied by an increase in PDI-like
activity. In this study, nearly all the mutants that we have
generated are less active than the WT protein, in contrast to
initial expections. Transforming the Grx active site into a Trx-
like active site did not improve the reactivity with NADP-
MDH or Trx reductase (data not shown). Similarly to what
is described here, simulations of Trx or Grx-like active sites in
tryparedoxin 2 did not result in Trx or Grx-like activities [43].
Overall, these data strongly suggest that the structural deter-
minants for Trx or Grx reactivity go beyond the sequence of
the active site.
Nevertheless, the series of mutants generated here help to
understand the functioning of plant Grxs. The catalytic cys-
teine as well as the importance of an aromatic residue inside
the regulatory sequence and adjacent to the backup cysteine
have been uncovered. An additional interesting ¢nding of this
study is the capacity of Grx to activate the NADP-MDH.
This enzyme has always been reputed as promiscuous as it
accepts many di¡erent Trxs as regulators, in contrast to fruc-
tose-1,6-biphosphatase that requires selectively Trx f. The
data presented here indicate that the DTT NADP-MDH ac-
tivation test should be used cautiously, as Grx is also active in
this process despite the fact that it probably does not act in a
catalytic way.
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